RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 18, Issue 3, 2000, Pages 391-393

  Makki, R F ^a   Sharif, F Al ^b   Gonzalez Gay M A ^c   Garcia Porrua C ^c   Ollier, W E R ^b   Hajeer, A H ^b  

^a BEIRUT ARAB UNIVERSITY   (Lebanon)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c HOSPITAL XERAL CALDE   (Spain)

Author keywords

Giant cell arteritis; Polymorphism; Polymyalgia rheumatica; RANTES; Rheumatoid arthritis

Indexed keywords

RANTES;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GIANT CELL ARTERITIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS;

ADULT; AGED; ALLELES; ARTHRITIS, RHEUMATOID; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMYALGIA RHEUMATICA; PROMOTER REGIONS (GENETICS); RANTES; TEMPORAL ARTERITIS;

EID: 0034086586     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. CHUANG TY, HUNDER GG, ILSTRUP DM, KURLAND GG: Polymyalgia rheumalica: A 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97: 672-80.
2. SALVARANI C, MACCHIONI PL, TARTONI PL et al.: Polymyalgia rheumatica and giant cell arteritis: A 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987; 5: 205-15.
3. SALVARANI C, MACCHIONI P, BOIARDI L: Polymyalgia rheumatica. Lancet 1997; 350: 43-7.
4. SALVARANI C, MACCHIONI P, BOIARDI L et al.: Suluble interleukin 2 receptors in polymyalgia rheumatica/giant cell. Clinical and laboratory correlations. J Rheumatol 1992; 19: 1100-6.
5. ROCHE NE, FULBRIGHT JW, WAGNER AD, HUNDER GG, GORONZY JJ, WEYAND CM: Correlation of interleukin-6 production and disease duration in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993; 36: 1286-94.
6. MACCHIONI P, BOIARDI L, MELICONI R, SALVARANI C, GRAZIA UGUCCIONI M, ROSSI F: Elevated soluble intercellular adhesion molecule-1 in the serum of patients with polymyalgia rheumatica : Influence of steroid treatment. J Rheumatol 1994; 21: 1860-4.
7. DASGUPTA B, DUKE O, TIMMS AM, PITZALIS C, PANAYI GS: Slective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1989; 48: 307-11.
8. BOIARDI L, SALVARANI C, MACCHIONI P, CASADEI MALDINI M, MANCINI R, BELTRANDI E: CD8 lymphocyte subsets in active polymyalgia rheumatica. Comparison with elderly-onset and adult rheumatoid arthritis and influence of prednisone therapy. Br J Rheumatol 1996; 35: 642-8.
9. PULSATELLI L, MELICONI R, BOIARDI L, MACCHIONI P, SALVARANI C, FACCHINI A: Elevated serum concentrations of the chemokine RANTES in patients with polymyalgia rheumatica. Clin Exp Rheumatol 1998; 16: 263-8.
10. FELDMANN M, BRENNAN FM, MAINI RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14 : 397-440.
11. SNOWDEN N, HAJEER A, THOMSON W, OLLIER B: RANTES role in rheumatoid arthritis. Lancet 1994; 343: 547-8.
12. SCHALL TJ, BACON K, TOY KJ, GOEDDEE DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-71.
13. ROT A, KRIEGER M, BRUNNER T, BISCHOFF SC, SCHALL TJ, DAHINDEN CA: RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992; 176: 1489-95.
14. HAJEER AH, AL SHARIF F, OLLIER WER: A polymorphism at position -403 in the human RANTES promoter. Eur J Immunogenet (in press).
15. DABABNEH A, GONZÁLEZ-GAY MA, GARCIA-PORRUA C, HAJEER A, THOMSON W, OLLIER W: Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II associations. J Rheumatol 1998; 25: 2146-55.
16. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The 1987 revised ARA criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 515-22.
17. ROBINSON E, KEYSTONE EC, SCHALL TJ, GILLETT N, FISH EN: Chemokine expression in rheumatoid arthritis (RA): Evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin & Exp Immunol 1995; 101: 398-407.
18. ORTIZ BD, NELSON PJ, KRENSKY AM: Switching gears during T-cell maturation: RANTES and late transcription. Immunol Today 1997; 18: 468-71.
19. WANG JH, DEVALIA JL, XIA C, SAPSFORD RJ, DAVIES RJ: Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 1996; 14: 27-35.
20. GONZáLEZ-GAY MA, GARCÍA-PORRÚA C, HAJEER A, OLLIER WE: Can HLA-DR explain the varying frequency of synovitis in polymyalgia rheumatica? Comment on the article by Salvarani et al. Arthritis Rheum 1999; 42: 1561-2.